LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 51

Search options

  1. Article: Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy.

    Baldari, Silvia / Di Modugno, Francesca / Nisticò, Paola / Toietta, Gabriele

    Cancers

    2022  Volume 14, Issue 19

    Abstract: The tumor stroma, which comprises stromal cells and non-cellular elements, is a critical component of the tumor microenvironment (TME). The dynamic interactions between the tumor cells and the stroma may promote tumor progression and metastasis and ... ...

    Abstract The tumor stroma, which comprises stromal cells and non-cellular elements, is a critical component of the tumor microenvironment (TME). The dynamic interactions between the tumor cells and the stroma may promote tumor progression and metastasis and dictate resistance to established cancer therapies. Therefore, novel antitumor approaches should combine anticancer and anti-stroma strategies targeting dysregulated tumor extracellular matrix (ECM). ECM remodeling is a hallmark of solid tumors, leading to extensive biochemical and biomechanical changes, affecting cell signaling and tumor tissue three-dimensional architecture. Increased deposition of fibrillar collagen is the most distinctive alteration of the tumor ECM. Consequently, several anticancer therapeutic strategies have been developed to reduce excessive tumor collagen deposition. Herein, we provide an overview of the current advances and challenges of the main approaches aiming at tumor collagen normalization, which include targeted anticancer drug delivery, promotion of degradation, modulation of structure and biosynthesis of collagen, and targeting cancer-associated fibroblasts, which are the major extracellular matrix producers.
    Language English
    Publishing date 2022-09-27
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers14194706
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Current Biomedical Use of Copper Chelation Therapy.

    Baldari, Silvia / Di Rocco, Giuliana / Toietta, Gabriele

    International journal of molecular sciences

    2020  Volume 21, Issue 3

    Abstract: Copper is an essential microelement that plays an important role in a wide variety of biological processes. Copper concentration has to be finely regulated, as any imbalance in its homeostasis can induce abnormalities. In particular, excess copper plays ... ...

    Abstract Copper is an essential microelement that plays an important role in a wide variety of biological processes. Copper concentration has to be finely regulated, as any imbalance in its homeostasis can induce abnormalities. In particular, excess copper plays an important role in the etiopathogenesis of the genetic disease Wilson's syndrome, in neurological and neurodegenerative pathologies such as Alzheimer's and Parkinson's diseases, in idiopathic pulmonary fibrosis, in diabetes, and in several forms of cancer. Copper chelating agents are among the most promising tools to keep copper concentration at physiological levels. In this review, we focus on the most relevant compounds experimentally and clinically evaluated for their ability to counteract copper homeostasis deregulation. In particular, we provide a general overview of the main disorders characterized by a pathological increase in copper levels, summarizing the principal copper chelating therapies adopted in clinical trials.
    MeSH term(s) Chelating Agents/chemistry ; Chelating Agents/pharmacology ; Chelating Agents/therapeutic use ; Chelation Therapy ; Clinical Trials as Topic ; Copper/chemistry ; Copper/metabolism ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/genetics ; Diabetes Mellitus/metabolism ; Gene Regulatory Networks/drug effects ; Homeostasis ; Humans ; Idiopathic Pulmonary Fibrosis/drug therapy ; Idiopathic Pulmonary Fibrosis/genetics ; Idiopathic Pulmonary Fibrosis/metabolism ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neoplasms/metabolism ; Parkinson Disease/drug therapy ; Parkinson Disease/genetics ; Parkinson Disease/metabolism ; Structure-Activity Relationship
    Chemical Substances Chelating Agents ; Copper (789U1901C5)
    Language English
    Publishing date 2020-02-06
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21031069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer.

    Di Nardo, Maddalena / Astigiano, Simonetta / Baldari, Silvia / Pallotta, Maria Michela / Porta, Giovanni / Pigozzi, Simona / Antonini, Annalisa / Emionite, Laura / Frattini, Annalisa / Valli, Roberto / Toietta, Gabriele / Soddu, Silvia / Musio, Antonio

    Journal of experimental & clinical cancer research : CR

    2024  Volume 43, Issue 1, Page(s) 49

    Abstract: Background: SMC1A is a subunit of the cohesin complex that participates in many DNA- and chromosome-related biological processes. Previous studies have established that SMC1A is involved in cancer development and in particular, is overexpressed in ... ...

    Abstract Background: SMC1A is a subunit of the cohesin complex that participates in many DNA- and chromosome-related biological processes. Previous studies have established that SMC1A is involved in cancer development and in particular, is overexpressed in chromosomally unstable human colorectal cancer (CRC). This study aimed to investigate whether SMC1A could serve as a therapeutic target for CRC.
    Methods: At first, we studied the effects of either SMC1A overexpression or knockdown in vitro. Next, the outcome of SMC1A knocking down (alone or in combination with bevacizumab, a monoclonal antibody against vascular endothelial growth factor) was analyzed in vivo.
    Results: We found that SMC1A knockdown affects cell proliferation and reduces the ability to grow in anchorage-independent manner. Next, we demonstrated that the silencing of SMC1A and the combo treatment were effective in increasing overall survival in a xenograft mouse model. Functional analyses indicated that both treatments lead to atypical mitotic figures and gene expression dysregulation. Differentially expressed genes were implicated in several pathways including gene transcription regulation, cellular proliferation, and other transformation-associated processes.
    Conclusions: These results indicate that SMC1A silencing, in combination with bevacizumab, can represent a promising therapeutic strategy for human CRC.
    MeSH term(s) Animals ; Humans ; Mice ; Bevacizumab/pharmacology ; Bevacizumab/therapeutic use ; Cell Cycle Proteins/metabolism ; Cell Proliferation ; Chromosomal Proteins, Non-Histone/genetics ; Cohesins/genetics ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/metabolism ; Gene Silencing ; Vascular Endothelial Growth Factor A/genetics
    Chemical Substances Bevacizumab (2S9ZZM9Q9V) ; Cell Cycle Proteins ; Chromosomal Proteins, Non-Histone ; Cohesins ; Vascular Endothelial Growth Factor A ; structural maintenance of chromosome protein 1
    Language English
    Publishing date 2024-02-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 803138-1
    ISSN 1756-9966 ; 0392-9078
    ISSN (online) 1756-9966
    ISSN 0392-9078
    DOI 10.1186/s13046-024-02976-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cancer immunity and immunotherapy beyond COVID-19.

    Bellone, Matteo / Brevi, Arianna / Bronte, Vincenzo / Dusi, Silvia / Ferrucci, Pier Francesco / Nisticò, Paola / Rosato, Antonio / Russo, Vincenzo / Sica, Antonio / Toietta, Gabriele / Colombo, Mario Paolo

    Cancer immunology, immunotherapy : CII

    2023  Volume 72, Issue 7, Page(s) 2541–2548

    MeSH term(s) Humans ; COVID-19 ; Immunotherapy ; Neoplasms/therapy ; Cancer Vaccines
    Chemical Substances Cancer Vaccines
    Language English
    Publishing date 2023-03-30
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 195342-4
    ISSN 1432-0851 ; 0340-7004
    ISSN (online) 1432-0851
    ISSN 0340-7004
    DOI 10.1007/s00262-023-03411-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells

    Di Rocco, Giuliana / Baldari, Silvia / Pani, Giovambattista / Toietta, Gabriele

    Cellular and molecular life sciences. 2019 Jan., v. 76, no. 2

    2019  

    Abstract: Stem cells drive embryonic and fetal development. In several adult tissues, they retain the ability to self-renew and differentiate into a variety of specialized cells, thus contributing to tissue homeostasis and repair throughout life span. Alcohol ... ...

    Abstract Stem cells drive embryonic and fetal development. In several adult tissues, they retain the ability to self-renew and differentiate into a variety of specialized cells, thus contributing to tissue homeostasis and repair throughout life span. Alcohol consumption is associated with an increased risk for several diseases and conditions. Growing and developing tissues are particularly vulnerable to alcohol’s influence, suggesting that stem- and progenitor-cell function could be affected. Accordingly, recent studies have revealed the possible relevance of alcohol exposure in impairing stem-cell properties, consequently affecting organ development and injury response in different tissues. Here, we review the main studies describing the effects of alcohol on different types of progenitor/stem cells including neuronal, hepatic, intestinal and adventitial progenitor cells, bone-marrow-derived stromal cell, dental pulp, embryonic and hematopoietic stem cells, and tumor-initiating cells. A better understanding of the nature of the cellular damage induced by chronic and episodic heavy (binge) drinking is critical for the improvement of current therapeutic strategies designed to treat patients suffering from alcohol-related disorders.
    Keywords adults ; alcohol drinking ; alcohols ; fetal development ; hematopoietic stem cells ; homeostasis ; intestines ; longevity ; neurons ; patients ; risk ; therapeutics ; tissues ; tooth pulp
    Language English
    Dates of publication 2019-01
    Size p. 231-244.
    Publishing place Springer International Publishing
    Document type Article
    Note Review
    ZDB-ID 1358415-7
    ISSN 1420-9071 ; 1420-682X
    ISSN (online) 1420-9071
    ISSN 1420-682X
    DOI 10.1007/s00018-018-2931-8
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cells.

    Di Rocco, Giuliana / Baldari, Silvia / Pani, Giovambattista / Toietta, Gabriele

    Cellular and molecular life sciences : CMLS

    2018  Volume 76, Issue 2, Page(s) 231–244

    Abstract: Stem cells drive embryonic and fetal development. In several adult tissues, they retain the ability to self-renew and differentiate into a variety of specialized cells, thus contributing to tissue homeostasis and repair throughout life span. Alcohol ... ...

    Abstract Stem cells drive embryonic and fetal development. In several adult tissues, they retain the ability to self-renew and differentiate into a variety of specialized cells, thus contributing to tissue homeostasis and repair throughout life span. Alcohol consumption is associated with an increased risk for several diseases and conditions. Growing and developing tissues are particularly vulnerable to alcohol's influence, suggesting that stem- and progenitor-cell function could be affected. Accordingly, recent studies have revealed the possible relevance of alcohol exposure in impairing stem-cell properties, consequently affecting organ development and injury response in different tissues. Here, we review the main studies describing the effects of alcohol on different types of progenitor/stem cells including neuronal, hepatic, intestinal and adventitial progenitor cells, bone-marrow-derived stromal cell, dental pulp, embryonic and hematopoietic stem cells, and tumor-initiating cells. A better understanding of the nature of the cellular damage induced by chronic and episodic heavy (binge) drinking is critical for the improvement of current therapeutic strategies designed to treat patients suffering from alcohol-related disorders.
    MeSH term(s) Aldehyde Dehydrogenase, Mitochondrial/metabolism ; Ethanol/pharmacology ; Humans ; Mesenchymal Stem Cells/cytology ; Mesenchymal Stem Cells/drug effects ; Mesenchymal Stem Cells/metabolism ; MicroRNAs/metabolism ; Neoplastic Stem Cells/cytology ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; Neural Stem Cells/cytology ; Neural Stem Cells/drug effects ; Neural Stem Cells/metabolism ; Reactive Oxygen Species/metabolism ; Stem Cells/cytology ; Stem Cells/drug effects ; Stem Cells/metabolism ; TOR Serine-Threonine Kinases/metabolism
    Chemical Substances MicroRNAs ; Reactive Oxygen Species ; Ethanol (3K9958V90M) ; Aldehyde Dehydrogenase, Mitochondrial (EC 1.2.1.3) ; TOR Serine-Threonine Kinases (EC 2.7.11.1)
    Language English
    Publishing date 2018-10-10
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 1358415-7
    ISSN 1420-9071 ; 1420-682X
    ISSN (online) 1420-9071
    ISSN 1420-682X
    DOI 10.1007/s00018-018-2931-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Reduction of Cell Proliferation by Acute C

    Baldari, Silvia / Manni, Isabella / Di Rocco, Giuliana / Paolini, Francesca / Palermo, Belinda / Piaggio, Giulia / Toietta, Gabriele

    Cancers

    2021  Volume 13, Issue 19

    Abstract: Endogenous acetaldehyde production from the metabolism of ingested alcohol exposes hematopoietic progenitor cells to increased genotoxic risk. To develop possible therapeutic strategies to prevent or reverse alcohol abuse effects, it would be critical to ...

    Abstract Endogenous acetaldehyde production from the metabolism of ingested alcohol exposes hematopoietic progenitor cells to increased genotoxic risk. To develop possible therapeutic strategies to prevent or reverse alcohol abuse effects, it would be critical to determine the temporal progression of acute ethanol toxicity on progenitor cell numbers and proliferative status. We followed the variation of the cell proliferation rate in bone marrow and spleen in response to acute ethanol intoxication in the MITO-Luc mouse, in which NF-Y-dependent cell proliferation can be assessed in vivo by non-invasive bioluminescent imaging. One week after ethanol administration, bioluminescent signals in bone marrow and spleen decreased below the level corresponding to physiological proliferation, and they progressively resumed to pre-treatment values in approximately 4 weeks. Boosting acetaldehyde catabolism by administration of an aldehyde dehydrogenase activity activator or administration of polyphenols with antioxidant activity partially restored bone marrow cells' physiological proliferation. These results indicate that in this mouse model, bioluminescent alteration reflects the reduction of the physiological proliferation rate of bone marrow progenitor cells due to the toxic effect of aldehydes generated by alcohol oxidation. In summary, this study presents a novel view of the impact of acute alcohol intake on bone marrow cell proliferation in vivo.
    Language English
    Publishing date 2021-10-05
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers13194999
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Successful Therapy of Esophageal Fistulas by Endoscopic Injection of Emulsified Adipose Tissue Stromal Vascular Fraction.

    Nachira, Dania / Trivisonno, Angelo / Costamagna, Guido / Toietta, Gabriele / Margaritora, Stefano / Pontecorvi, Valerio / Punzo, Giovanni / Porziella, Venanzio / Boškoski, Ivo

    Gastroenterology

    2021  Volume 160, Issue 4, Page(s) 1026–1028

    MeSH term(s) Adipose Tissue/cytology ; Cell Separation ; Esophageal Fistula/therapy ; Esophagoscopy/methods ; Follow-Up Studies ; Humans ; Stromal Cells/transplantation ; Transplantation, Autologous/methods ; Treatment Outcome
    Language English
    Publishing date 2021-01-05
    Publishing country United States
    Document type Journal Article ; Video-Audio Media
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2020.12.063
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for

    Di Rocco, Giuliana / Baldari, Silvia / Toietta, Gabriele

    Stem cells international

    2016  Volume 2016, Page(s) 5029619

    Abstract: Extracellular vesicles (EVs), such as microvesicles and exosomes, are membranous structures containing bioactive material released by several cells types, including mesenchymal stem/stromal cells (MSCs). Increasing lines of evidences point to EVs as ... ...

    Abstract Extracellular vesicles (EVs), such as microvesicles and exosomes, are membranous structures containing bioactive material released by several cells types, including mesenchymal stem/stromal cells (MSCs). Increasing lines of evidences point to EVs as paracrine mediators of the beneficial effects on tissue remodeling associated with cell therapy. Administration of MSCs-derived EVs has therefore the potential to open new and safer therapeutic avenues, alternative to cell-based approaches, for degenerative diseases. However, an enhanced knowledge about
    Language English
    Publishing date 2016-11-23
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 2573856-2
    ISSN 1687-9678 ; 1687-966X
    ISSN (online) 1687-9678
    ISSN 1687-966X
    DOI 10.1155/2016/5029619
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Extracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell Proliferation.

    Baldari, Silvia / Di Rocco, Giuliana / Magenta, Alessandra / Picozza, Mario / Toietta, Gabriele

    Cells

    2019  Volume 8, Issue 12

    Abstract: Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer and one of the prominent causes of cancer mortality, leading to approximately 780,000 deaths per year worldwide. Down-regulation of microRNA-125b (miR-125b) is a prognostic ... ...

    Abstract Hepatocellular carcinoma (HCC) is the most frequent type of primary liver cancer and one of the prominent causes of cancer mortality, leading to approximately 780,000 deaths per year worldwide. Down-regulation of microRNA-125b (miR-125b) is a prognostic indicator in HCC patients. Conversely, over-expression of miR-125b in HCC cells induces cell cycle arrest, inhibits proliferation, migration and invasion. Extracellular vesicles (EVs) function as intercellular messengers transferring proteins, RNAs, DNAs, carbohydrates, and lipids. Since EVs protect their cargo from degradation, delivery of therapeutic bioactive molecules, in particular miRNAs, through EVs represents an innovative avenue for cancer therapy. In this study, we evaluated a replacement strategy for the treatment of HCC via delivery of EVs secreted from human adipose tissue-derived mesenchymal stromal/medicinal signaling cells (ASCs) genetically modified with a lentiviral vector expressing miR-125b with a specific ExoMotif sequence tag to enhance the loading into extracellular vesicles. In particular, we determined that the delivery of miR-125b-loaded EVs produced in engineered ASCs specifically reduces HCC cell proliferation in vitro modulating a series of miR-125b targets, which belong to the p53 signaling pathway. This proof-of-concept study supports the development of innovative therapeutic strategies for HCC via EV-mediated miRNA delivery.
    MeSH term(s) Adipose Tissue/metabolism ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Carcinoma, Hepatocellular/pathology ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Extracellular Vesicles/metabolism ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Liver Neoplasms/pathology ; Mesenchymal Stem Cells/metabolism ; MicroRNAs/genetics ; Transduction, Genetic ; Tumor Suppressor Protein p53
    Chemical Substances MIRN125 microRNA, human ; MicroRNAs ; TP53 protein, human ; Tumor Suppressor Protein p53
    Language English
    Publishing date 2019-12-03
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells8121560
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top